Introduction The American Journal of Medicine

Slides:

Advertisements

Similar presentations

Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.

Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

From: Risks of Cardiovascular Adverse Events and Death in Patients with Previous Stroke Undergoing Emergency Noncardiac, Nonintracranial Surgery:The Importance.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

The Epidemic of the 20th Century: Coronary Heart Disease

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

EMPA-REG OUTCOME: The Endocrinologist's Point of View

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Wayne S. Dysinger, MD, MPH, James M. Pappas, MD, MBA

Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Matthew A. Cavender, MD, MPH, Benjamin M

EMPA-REG OUTCOME: The Endocrinologist's Point of View

EMPA-REG OUTCOME: The Cardiologist's Point of View

Jason Thomas, MD, Erica Saenz, MD, Paul Haggerty, MD

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials Kenneth R. McQuaid, MD, Loren.

Wandering Acute Myocardial Infarction

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials Giulia Renda, MD, PhD, Marta.

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,

Epidemiology of Myelodysplastic Syndromes

Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States Vikas Singh, MD, Alex P. Rodriguez, MD, Badal Thakkar, MD, MPH, Ghanshyambhai.

Lessons Learned: Role of Influenza Vaccine Production, Distribution, Supply, and Demand—What It Means for the Provider Walter A. Orenstein, MD, William.

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

The Epidemic of the 20th Century: Coronary Heart Disease

Carotid Sinus Massage in Patients with Suspected Acute Myocardial Infarction, Tachycardia, and Left Bundle Branch Block Teddy Weiss, MD, Yair Elitzur,

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Medical professionalism and the generation gap

Jane S. Saczynski, PhD, Darleen Lessard, MS, Frederick A

Muhammad Amer, MD, MHS, FACP, Rehan Qayyum, MD, MHS

The Reply The American Journal of Medicine

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

Gun Ownership and Firearm-related Deaths

Gout in African Americans

Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis G. Caleb Alexander, MD, MS, Geetha Iyer, MBBS, Eleanor.

When Guidelines Cause Hypertension

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Chapter 2 Demographics Journal of Obstetrics and Gynaecology Canada

Support Your Specialty

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal.

Shelley R. Salpeter, MD, Peter Gregor, MD, Thomas M

Yader Sandoval, MD, Stephen W. Smith, MD, Sara A

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

MATCH Results: Implications for the Internist

Insomnia in the Elderly: Cause, Approach, and Treatment

To Reduce Stroke with PFO Closure, Respect the Shunt

Role of Niacin in Current Clinical Practice: A Systematic Review

Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction Salman A. Haq, MD, John F. Heitner, MD, Terrence J.

A Review of Learner Impact on Faculty Productivity

Late to the Feast: Primary Care and US Health Policy

Jonathan R. Dalzell, MBChB, MRCP, Colette E

Cardiovascular risk assessment in kidney transplantation

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Tombstone ST Elevations: … Not Necessarily a Harbinger of Doom!

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

Direct Observation of Residents: A Model for an Assessment System

Falls in Older Adults: Risk Assessment, Management and Prevention

Toward a More Responsible News Media

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Incretin Therapies: Effects Beyond Glycemic Control

Fig. 1. The composite analysis of the risk of major adverse cardiovascular events (MACEs) from three cardiovascular outcome trials, expressed as relative.

Presentation transcript:

Introduction The American Journal of Medicine Robert Chilton, DO The American Journal of Medicine Volume 130, Issue 6, Pages S1-S3 (June 2017) DOI: 10.1016/j.amjmed.2017.04.003 Copyright © 2017 Terms and Conditions

Figure EMPA-REG OUTCOME: summary of trial population and key results. MACE = major adverse cardiovascular event (3-point MACE, composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke).5,7,8 The American Journal of Medicine 2017 130, S1-S3DOI: (10.1016/j.amjmed.2017.04.003) Copyright © 2017 Terms and Conditions